Nicotine vs Ozempic: The Shocking Truth About Fat Loss
Thomas DeLauer — Nicotine vs Ozempic: The Shocking Truth About Fat Loss
Channel: Thomas DeLauer · Our label: Nutrition & fasting creator · Source: youtube.com/watch?v=Tqd4t6G0NTE
What this video covers
Nicotine acts upon a particular receptor that’s in the white atapose tissue and can have a pretty profound effect on fat loss really and definitely a profound effect on hunger. Then you have something like a GLP-1 receptor agonist like Mjaro oric which is working upon a different axis. It’s not directly working upon fat loss but it’s working upon sort of these satiety signals in your gut. They both have their drawbacks and they’re both in a lot of ways like some may disagree but they’re kind of equally controversial at least in terms of how it’s…
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Then you have something like a GLP-1 receptor agonist like Mjaro oric which is working upon a different axis.
- So I want to just discuss them straight up and help us understand like what works for what and if there’s any true validity to them working for fat loss in a safe effective way.
- You can look at their trust score where they third party test a lot of things to see if brands are what they say they are.
- They help you organize your stack so you can kind of determine what supplements you’re using and when you take them.
- So first I want to start off with a study that was looking at how nicotine impacted body fat in a particular rodent model study.
- But the early research with GLP-1 receptor agonist was actually much more in the world of mitochondrial health and helping the mitochondria utilize glucose better.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.